We could not observe a role of estrogens or GPER1 in cell proliferation (i.e., under normoxic conditions), but we did show an effect on key CRC lesions, that is, CA and w-CIN that may contribute to tumorigenesis, tumor progression, or therapy resistance (7, 8). The gene discussed is GPER1; the disease is colorectal carcinoma.